Genmab — April 2017

[bibob]

Yes E L. I know that. I am just a bit sarcastic. Sorry

[E_L]

haha, ok, and hope you are enjoying your holiday lol. expensive holiday for some...

[bibob]

Yes I think so. Hopefully they will come back on track.

[E_L]

i am actually convinced this fall was orchestrated to a certain extent. I am sure some parties have made a killing on some shorts the last 2 weeks

[Darvin]

Nordea gentog "køb" her i eftermiddag - og nu 49 studier med Dara. 14 linjer mht solide tumorer

[bibob]

A wery lot to look forward against.

[JKY_VH]

Tak Darvin, det lyder godt.

[Helge_LarsenPI-redaktør]

49? Det er så 12 mere på nogle få dage?

[JKY_VH]

stigningen er nok eksponentiel Helge:-)

[E_L]

i think the 49 is wrong. that is what you get when searching for dara in clinicaltrials.gov. However, 5 of those are not really dara studies (but look at eg if you are dara relapsed) , 1 is withdrawn, 1 completed, 'available' and the last 1 we know really well was STOPPED

[E_L]

i'll check and put it in a spread sheet

[Helge_LarsenPI-redaktør]

Se listen på investorpræsentationen fra April 2017.

[Darvin]

Ok undskyld de 49

[Helge_LarsenPI-redaktør]

Det lød ellers godt.

[E_L]

40 is still a lot. and that is only dara.

[Helge_LarsenPI-redaktør]

Prøv at tænke på vore mange penge der er investeret i de 40 forsøg.

[Helge_LarsenPI-redaktør]

Og hvor meget tiltro der er til Dara fra alle dem som vil havestoffet med i en kombi med deres egne midler.

[Bulder]

Helge, hvor finder man den præsentation fra april 17?

[Solsen]

Impressing program in solid tumors. winkel recently said 14 different tumors. Novod list all clinical trials in in solid tumors in his flash today.

[Bulder]

Gentager han så også, hvilket studie, der data fra mid-17?